๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Antisense therapy for lymphomas

โœ Scribed by Finbarr E. Cotter


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
58 KB
Volume
15
Category
Article
ISSN
0278-0232

No coin nor oath required. For personal study only.

โœฆ Synopsis


๏ซ๏ฅ๏น ๏ท๏ฏ๏ฒ๏ค๏ณ antisense; BCL-2; apoptosis; lymphoma 'gene silencing', by synthetic oligonucleotides, as a therapeutic tool. In the field of lymphomas obvious targets include follicular lymphoma with the t(14;18) translocation, deregulated expression of the BCL-2 gene, chemoresistance and subsequent protection against lymphoma cell death.

Binding of a sequence-specific oligonucleotide to a targeted length of mRNA should occur with a high level of specificity. The resultant formation of the mRNA-DNA duplex would, if the relevant portion of mRNA has been targeted, suppress the translation of the targeted message into protein. If the production of that protein, such as BCL-2, is essential for the survival of the


๐Ÿ“œ SIMILAR VOLUMES


Combined therapy for cutaneous t-cell ly
โœ Lourdes Z. Niscel; Bijan Safai; Rosa Ong; Sanford Kempin; Hipolito-Rosillo Pouss ๐Ÿ“‚ Article ๐Ÿ“… 1981 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 179 KB
Radiation therapy for intraocular lympho
โœ J.Lillian Chou; Duane E. Myers; Mary E. Young; James D. Easley ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 113 KB
Monoclonal antibody therapy for lymphoma
โœ Peter Campbell; Robert Marcus ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 139 KB

Monoclonal antibodies are an exciting advance in the treatment of lymphoma. They are safe and well-tolerated, and exhibit little cross-resistance with conventional chemotherapeutic agents. In indolent lymphomas, antibody therapy has shown useful response rates, both as first-line therapy and in rela

Radiation therapy for primary orbital ly
โœ Cliff K.S. Chao; Hsiu-san Lin; V. Rao Devineni; Morton Smith ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 467 KB
Antisense MBD2 gene therapy inhibits tum
โœ Andrew Slack; Veronica Bovenzi; Pascal Bigey; M. A. Ivanov; Shyam Ramchandani; S ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 396 KB

## Abstract ## Background Aberration in the pattern of DNA methylation is one of the hallmarks of cancer. We present data suggesting that dysregulation of MBD2, a recently characterized member of a novel family of methylated DNA binding proteins, is involved in tumorigenesis. Two functions were as